Aed peptide
Aed peptide has been studied in 2 papers since 2023: none in people yet, 2 in cells. No study of it in people or animals has been published yet. The newest paper, Jan 1, 2023: “The influence of peptides on the chondrogenic differentiation of human mesenchymal stem cells during replicative aging”.
2 papers study it2 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Cells2
What did studies of Aed peptide find?
2Studies of Aed peptide measured 2 outcomes; the most studied are stem cell differentiation (1 study) and senescence-associated secretory phenotype (SASP) (1).
Stem cell differentiation
upin human cells1
1 study
Stem cell differentiation
upin human cells1
Aed peptide induces stem cell differentiation in human cells.
“AED peptide at the concentration of 200 ng/ml activates gene expression and protein synthesis during aging of MSCs.”
Cellsduring replicative aging200 ng/ml
Advances in gerontology = Uspekhi gerontologii
Senescence-associated secretory phenotype (SASP)
downin cells1
1 study
Senescence-associated secretory phenotype (SASP)
downin cells1
Aed peptide inhibits senescence-associated secretory phenotype (SASP) in cells.
“Peptides AED and CPC normalize the synthesis of molecules that form SASP of chondrocytes.”
Cells
Peptides prevent the forming of secretory phenotype of chondrocytes associated with the aging
Advances in gerontology = Uspekhi gerontologii